Skip Navigation



JAC Advance Access published online on April 14, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg223
© 2003 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
51/5/1167    most recent
dkg223v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Seral, C.
Right arrow Articles by Van Bambeke, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seral, C.
Right arrow Articles by Van Bambeke, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The British Society for Antimicrobial Chemotherapy

Original article

Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus

Cristina Seral 1, Stéphane Carryn 1, Paul M. Tulkens 1*, Françoise Van Bambeke 1

1 Unité de Pharmacologie Cellulaire et Moléculaire, Université Catholique de Louvain, UCL 73.70 Avenue E. Mounier 73, B-1200 Brussels, Belgium

* Corresponding author. E-mail: tulkens{at}facm.ucl.ac.be.

Received 20 January 2003 ; revised 3 February 2003 ; accepted 20 February 2003

Abstract

Antibiotic efflux pumps expressed in eukaryotic cells can decrease the intracellular accumulation of the corresponding drugs and therefore impair their activity against intracellular bacteria. We have investigated whether verapamil (an inhibitor of P-glycoprotein) and gemfibrozil (an inhibitor of multidrug resistance proteins (MRP) and other organic anion transporters), can modulate the intracellular activity of azithromycin and ciprofloxacin against Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. In parallel, we have measured the cell accumulation and subcellular distribution of both drugs. Antibiotics were used at equipotent extracellular concentrations (from 0.5 x to 10 x MIC) to allow for pharmacological comparisons. Azithromycin was bacteriostatic against L. monocytogenes and slightly bactericidal against S. aureus. Verapamil did not improve the maximal activity of azithromycin but allowed it to reach a similar effect at extracellular concentrations about seven-fold lower in both models. Azithromycin was predominantly localized in cell granules (66%), the remainder being in the cytosol and in the ‘nuclei/unbroken cells' fraction. Verapamil increased the cellular accumulation of azithromycin by almost 2.4-fold without modifying its subcellular distribution. Ciprofloxacin displayed a strong concentration-dependent bactericidal activity in both models. Gemfibrozil increased ciprofloxacin activity almost 2.5-fold against L. monocytogenes, but not against S. aureus. Ciprofloxacin was predominantly (65%) distributed in the cytosol. Gemfibrozil increased ciprofloxacin total accumulation by ~2.4-fold, but the excess was only found in the cytosol. Inhibition of efflux pumps may be a useful strategy to improve antibiotic efficacy against intracellular bacteria when increased accumulation can be obtained in the compartment where bacteria sojourn.

Keywords: transporters, intracellular, accumulation, verapamil, gemfibrozil
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
K. S. Brinch, A. Sandberg, P. Baudoux, F. Van Bambeke, P. M. Tulkens, N. Frimodt-Moller, N. Hoiby, and H.-H. Kristensen
Plectasin Shows Intracellular Activity against Staphylococcus aureus in Human THP-1 Monocytes and in a Mouse Peritonitis Model
Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4801 - 4808.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Lemaire, F. Van Bambeke, and P. M. Tulkens
Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3734 - 3743.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Van de Velde, H. A. Nguyen, F. Van Bambeke, P. M. Tulkens, J. Grellet, V. Dubois, C. Quentin, and M.-C. Saux
Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes
J. Antimicrob. Chemother., September 1, 2008; 62(3): 518 - 521.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Lismond, P. M. Tulkens, M.-P. Mingeot-Leclercq, P. Courvalin, and F. Van Bambeke
Cooperation between Prokaryotic (Lde) and Eukaryotic (MRP) Efflux Transporters in J774 Macrophages Infected with Listeria monocytogenes: Studies with Ciprofloxacin and Moxifloxacin
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3040 - 3046.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Lemaire, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens
Modulation of the Cellular Accumulation and Intracellular Activity of Daptomycin towards Phagocytized Staphylococcus aureus by the P-Glycoprotein (MDR1) Efflux Transporter in Human THP-1 Macrophages and Madin-Darby Canine Kidney Cells
Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2748 - 2757.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. A. Nguyen, J. Grellet, V. Dubois, M.-C. Saux, and C. Quentin
Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus
J. Antimicrob. Chemother., April 1, 2007; 59(4): 755 - 758.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. K. Shandil, R. Jayaram, P. Kaur, S. Gaonkar, B. L. Suresh, B. N. Mahesh, R. Jayashree, V. Nandi, S. Bharath, and V. Balasubramanian
Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of In Vitro and Pharmacodynamic Indices That Best Predict In Vivo Efficacy
Antimicrob. Agents Chemother., February 1, 2007; 51(2): 576 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J.-M. Michot, M. F. Heremans, N. E. Caceres, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke
Cellular accumulation and activity of quinolones in ciprofloxacin-resistant j774 macrophages.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1689 - 1695.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. A. Nguyen, J. Grellet, D. Paillard, V. Dubois, C. Quentin, and M.-C. Saux
Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model
J. Antimicrob. Chemother., May 1, 2006; 57(5): 883 - 890.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
O. Langer, R. Karch, U. Muller, G. Dobrozemsky, A. Abrahim, M. Zeitlinger, E. Lackner, C. Joukhadar, R. Dudczak, K. Kletter, et al.
Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans
J. Nucl. Med., November 1, 2005; 46(11): 1835 - 1841.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J.-M. Michot, C. Seral, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens
Influence of Efflux Transporters on the Accumulation and Efflux of Four Quinolones (Ciprofloxacin, Levofloxacin, Garenoxacin, and Moxifloxacin) in J774 Macrophages
Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2429 - 2437.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. Seral, M. Barcia-Macay, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages
J. Antimicrob. Chemother., April 1, 2005; 55(4): 511 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
F. Van Bambeke, S. Carryn, C. Seral, H. Chanteux, D. Tyteca, M.-P. Mingeot-Leclercq, and P. M. Tulkens
Cellular Pharmacokinetics and Pharmacodynamics of the Glycopeptide Antibiotic Oritavancin (LY333328) in a Model of J774 Mouse Macrophages
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2853 - 2860.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J.-M. Michot, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens
Active Efflux of Ciprofloxacin from J774 Macrophages through an MRP-Like Transporter
Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2673 - 2682.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
S. N. A. Qazi, S. E. Harrison, T. Self, P. Williams, and P. J. Hill
Real-Time Monitoring of Intracellular Staphylococcus aureus Replication
J. Bacteriol., February 15, 2004; 186(4): 1065 - 1077.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.